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Supplemental Table 1 Baseline characteristics of study sample included and excluded for the 







Birth year     
    <1940 6.5 2.1 <0.0001 
    1940-1949 66.2 71.2  
    1950-1959 27.4 26.7  
Race/ethnicity    
    Caucasian- Australian/New Zealander  45.5 65.9 <0.0001 
    Caucasian- European  32.3 22.3  
    Caucasian- American  9.6 3.3  
    Japanese  2.3 0.1  
    African American/Black 5.1 1.3  
    Other 5.3 7.1  
Education level    
    ≤10 years 42.1 47.4 <0.0001 
    11-12 years 17.6 17.0  
    >12 years 40.3 35.7  
Body mass index    
    Normal weight (<25 kg/m2) 49.1 45.9 0.0003 
    Overweight (25-29.9 kg/m2) 30.3 31.1  
    Obese (≥30 kg/m2) 20.6 22.9  
Smoking status     
    Never  55.2 53.8 0.0012 
    Past smoker  28.5 27.5  
    Current smoker  16.3 18.7  
Menopausal status     
    Hysterectomy/oophorectomy  18.6 25.1 <0.0001 
    Unknown due to hormone use   14.6 16.6  
    Premenopause 20.3 20.2  
    Perimenopause  30.1 24.2  
    Natural postmenopause  16.3 13.9  
Current use of menopausal hormone therapy      
    No 79.7 75.9 <0.0001 
    Yes  20.3 24.1  
Frequency/severity of sleep difficulties    
    Never  40.1 34.9 <0.0001 
    Rarely/mild  23.1 19.1  
    Sometimes/moderate 24.0 29.8  
    Often/severe 12.8 16.2  
Frequency/severity of vasomotor symptoms    
    Never  44.9 42.2 <0.0001 
    Rarely/mild  20.4 17.1  
    Sometimes/moderate 20.7 24.7  
    Often/severe 14.0 16.1  
Frequency/severity of depressed mood    
    Never  51.8 51.7 0.0009 
    Rarely/mild  25.2 23.1  
    Sometimes/moderate 16.6 18.8  
    Often/severe 6.4 6.4  
 Supplemental Figure 1 Forest plot of study-specific effect estimates of the cross-sectional 
association between vasomotor symptoms and depressed mood at baseline. Odds ratios (ORs) were 
presented on a log scale. Effect estimates were fully adjusted for menopausal status, concurrent use 
of menopausal hormone therapy, race/ethnicity, education, smoking status, and BMI. Data for 
SWAN were additionally adjusted for study site.  
